Press Release

Marine Derived Drugs Market to Grow with a CAGR of 9.18% through 2028

The rich biodiversity of marine ecosystems and the urgent need for novel medical solutions are expected to drive the Global Marine Derived Drugs Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Marine Derived Drugs Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Marine Derived Drugs Market stood at USD 10.38 billion in 2022 and is anticipated to grow with a CAGR of 9.18% in the forecast period, 2024-2028. This can be attributed to regulatory support and environmental responsibility. Governments and regulatory bodies around the world are becoming increasingly supportive of marine biotechnology research and development. They recognize the potential economic and medical benefits of marine-derived drugs and are implementing policies and initiatives to encourage sustainable and responsible exploration of marine resources. This support helps create a conducive environment for growth in the industry. Moreover, neurological disorders, such as Alzheimer's and Parkinson's diseases, present significant medical challenges. Marine-derived compounds with neuroprotective and neuroregenerative properties are being investigated as potential treatments for these conditions. These compounds have the potential to slow down or even reverse the progression of neurodegenerative diseases.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Marine Derived Drugs Market.”

 

The global marine-derived drugs market refers to the pharmaceutical sector that harnesses bioactive compounds and substances from marine organisms, such as algae, sponges, corals, and marine microorganisms, to develop drugs and therapeutics for various medical applications. The Global Marine Derived Drugs Market is segmented into type, source, application, regional distribution, and company.

Based on its type, Peptide is poised to dominate the Global Marine Derived Drugs Market and sustain its supremacy throughout the forecasted years for several compelling reasons. Firstly, peptides offer unique advantages in drug development, characterized by their high specificity and low toxicity, making them ideal candidates for addressing complex medical conditions. Additionally, the abundance of marine biodiversity, coupled with advancements in biotechnology, has led to the discovery of novel marine-derived peptides with remarkable therapeutic potential. Peptide-based drugs have already demonstrated their efficacy in treating various diseases, including cancer and neurodegenerative disorders, further solidifying their position in the market. Moreover, as the global healthcare landscape continues to evolve towards personalized medicine and targeted therapies, peptides are well-positioned to play a pivotal role due to their precision and minimal side effects. With ongoing research and development efforts, Peptide is set to maintain its dominance in the Global Marine Derived Drugs Market, providing innovative solutions for healthcare challenges worldwide.

Based on source, Algae is poised to dominate the Global Marine Derived Drugs Market and sustain its dominance throughout the forecasted years due to several key factors. First and foremost, algae-based compounds offer a rich source of bioactive molecules with a wide range of potential therapeutic applications. Their sustainable cultivation practices align with the growing global emphasis on eco-friendly and renewable resources, making them a preferred choice for pharmaceutical development. Moreover, algae-derived drugs have already demonstrated success in treating conditions such as inflammation, diabetes, and cardiovascular diseases, and ongoing research continues to uncover new therapeutic potentials. Additionally, as consumers increasingly seek natural and plant-based alternatives, algae-based drugs are well-positioned to meet this demand. With continuous innovation, investment, and a commitment to sustainable practices, algae is set to maintain its dominance in the Global Marine Derived Drugs Market, contributing to advancements in healthcare and environmental sustainability.

 

Major companies operating in Global Marine Derived Drugs Market are:

  • Abbott Laboratories Inc
  • Bayer AG
  • Takeda Pharmaceutical Co Ltd
  • Marine Polymer Technologies Inc
  • Sanofi SA
  • Aphios Corp
  • Aker BioMarine ASA
  • AbbVie Inc
  • GSK PLC

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The global marine-derived drugs market is entering an era of rapid innovation and discovery. With advancements in genomics, deep-sea exploration, and microbiome-based therapies, the industry is poised to unveil a host of novel drug candidates that could revolutionize healthcare. From anti-inflammatory agents to cancer therapies and neuroprotective compounds, the potential applications of marine-derived drugs are vast and diverse. Collaborations and partnerships across the industry will play a critical role in harnessing these opportunities and bringing them to market,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Marine Derived Drugs Market By Type (Ether, Peptide, Phenol, Steroid), By Source (Algae, Invertebrates, Microorganisms), By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Marine Derived Drugs Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Marine Derived Drugs Market.


Contact

Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: www.techsciresearch.com               

Relevant News